Anti-malaria drug development targeting the M1 alanyl and M17 leucyl aminopeptidases

by Karine Thivierge, Rency T. Mathew, Desire M. M. Nsangou, Fabio Da Silva, Sophie Cotton, Tina S. Skinner-Adams, Katharine R. Trenholme, Christopher L. Brown, Colin M. Stack, Donald L. Gardiner, John P. Dalton
Published 2012-06-01